other HCV Information

HISTORY OF HCV

GLOSSARY/ABBREVIATIONS

LIVER FUNCTIONS

QUESTIONS ABOUT HCV

EXTRAHEPATIC CONDITIONS

SYMPTOMS

TRANSMISSION

SEXUAL TRANSMISSION

HCV BLOOD TESTS/LABS

LABS ON TREATMENT

BIOPSY RESULTS

ALTERNATIVE TO BIOPSY

STILL NEED A BIOPSY ?

ON BIOPSY WHAT DOES THE STAGE MEAN AND WHAT DOES THE GRADE ME ?

STAGES/LIVER DISEASE

FIBROSIS

CIRRHOSIS

TRANSPLANTS

LIVER CANCER

GENOTYPES

VIRAL LOAD

PEGASYS/ PEGINTRON

INFERGEN

HELP/SIDE EFFECTS

DRUG INTERACTIONS

NUTRITION  & HCV

TREATMENT STORIES

FIRST SHOT

INTERVIEWS

FIND A DOCTOR

FINANCIAL AID/MED ETC

SUPPORT GROUPS/TRANSPLANTS

HCV SUPPORT GROUPS

PICTURES Of OUR FRIENDS

INFORMATIONAL LINKS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This Web Site is committed to the memory of Janis Morrow.

Human liver   

Transplants

2007

Back to Index


Dec


Nexavar First FDA-Approved Drug Therapy for Liver Cancer

Change in Liver Transplant Criteria Reduced Waiting List Deaths

Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin vs No Prophylaxis after Liver Transplantation

Invention Offers Sick Livers a Well-Needed Rest

HCV Treatment Aided by New Platelet-Boosting Drug
 


Nov

From The : 58th Annual Nov 2007 AASLD Meeting


Liver Transplantation: 

Information on allocation of livers, recurrent HCV after transplantation, treatment of HCV before and after liver transplantation, post transplantation disease progression, and long term outcomes after liver transplantation

·        Allocation/General

o       601. Assessment of liver transplant candidates by an addiction medicine specialist : a prospective study

o       611. Development of a UK Score for Patients with End-stage Liver Disease

o       612. Proposal of New Selection Criteria for Living Donor Liver Transplantation Candidates for Hepatocellular Carcinoma

o       625. Should donor organs and recipients be matched in liver transplantation? An analysis of the United Kingdom and Ireland Liver Transplant Database

 

·        Allocation/MELD

o       552. MELD-Na is superior to other organ allocation systems   (updated November 5, 2007)

o       564. Implementation of a liver allocation system based on MELD score in three transplant centers of the same city. Can the score differences be solved? (updated November 5, 2007)

o       598. Hepatocellular Carcinoma (HCC) in Patients with HCV versus non-HCV Cirrhosis: Graft and Patient Survival after Liver Transplantation (LT) in Pre-MELD and MELD Era

o       603. Long Term Outcomes Of Liver Transplantation In A High-MELD Cohort

o       618. High MELD scores do not predict one-year survival rate of patients with a small-for-size graft in adult living donor liver trasplantation

o       624. Does Health Related Quality of Life Correlate with the Model for End Stage Liver Disease Score Before Liver Transplantation?

 

·        General

o       521. Chronic hepatitis E : a new entity in organ transplant patients (updated November 4, 2007)

o       527. Comparison between hepatic elasticity measurements (Fibroscan®) and liver biopsy in patients transplanted for HCV cirrhosis (updated November 4, 2007)

o       533. High Prevalence of Glomerulonephritis in Patients with End-stage HCV-induced Cirrhosis (updated November 4, 2007)

o       543. What is the risk of HBV transmission in recipients of liver graft from HBc Positive Antibody, HBs Negative Antigen donors? A single center experience over 10 years

o       561. Combined liver heart transplantation in the United States (updated November 5, 2007)

o       576. Sexual dysfunction before and after liver transplantation (LT)

o       589. Pre-transplant variables predict qualify of life in liver transplant recipients

o       602. The Readability of Health Education Materials for Liver Transplant Patients (updated November 5, 2007)

o       621. Use of Donation-after-Cardiac-Death (DCD) Donors for Combined Liver and Kidney Transplantation

 


Imaging May Help Diagnose Hepatic Encephalopathy

Insulin Resistance and Diabetes

Propranolol Better First-Line Prophylaxis Than Ligation for Variceal Bleeding

Researching Cure For Liver Cirrhosis

Minimal Hepatic Encephalopathy Associated With Increased Traffic Accidents

Propranolol Better First-Line Prophylaxis Than Ligation for Variceal Bleeding

Continue reading "The First Liver Transplant to Erase Hepatitis C" 

Driving With Minimal Hepatic Encephalopathy: Real World Consequences?

Symptoms of Liver Disease & Risk Factors for Upper GI Bleeding

Prevention of Variceal Bleeding in Candidates Awaiting Liver Transplantation

Outcomes after Liver Re-transplantation in Patients with Recurrent Chronic Hepatitis C

The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection: only detects cirrhosis

Coffee Consumption May Reduce the Risk of Liver Cancer

Sodium Levels Can Help Predict Outcomes before and after Liver Transplantation

Bishop of Athens to Undergo Liver Transplant

Rare Liver Transplant with Child is Successful

DDW 2007 Highlights: Part 2

Calderdale liver disease warning

Liver transplants one step closer

Strategies for the Management of Hepatocellular Carcinoma

Treatment of Recurrent Hepatitis C in Liver Transplant Recipients

Natural History of Hepatitis C in Patients with Severe Liver Fibrosis

Three Studies Assess Consensus Interferon for Hepatitis C in Prior Non-responders, Relapsers and Patients with a High Likelihood of Treatment Failure

Hepatitis C Treatment in Liver Transplant Recipients

'Virtual Patient' To Simulate Real-time Organ Motions For Radiation Therapy

New acute liver failure research from University of Texas, Department of Internal Medicine outlined

Special Hepatic Issues and Populations: Expert Analysis From EASL

International Registry Planned for Live Donor Transplant Outcomes

Clinical course of hepatitis C virus infection in renal transplant recipients.

DDW: Hepatitis C Patients Benefit with New Livers from HCV ...

HCV patients survival after liver transplantation is not improving

 recipients.Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients

Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation

Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis

Interferon Gamma Does Not Reverse Fibrosis in Hepatitis C Patients with Advanced Liver Disease  

Heavy Alcohol Use Worsens Disease Progression in Women with Chronic Hepatitis C

Liver Transplantation for Hepatitis C Patients

    Cancer’s Silver Lining

Improving Quality Of Life For Patients With Cirrhosis

Most Americans Don't Understand Acetaminophen Dangers

Older donor allografts are associated with poor patient survival after living do

Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial (HALT-C Study)

Liver transplant: Treating end-stage liver disease

Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients
with recurrent hepatitis C.

Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?

Selective Use of Older Adults in Right Lobe Living Donor Liver Transplantation

Nontransplantation of Livers from Deceased Donors Who Are Able to Donate Another

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.

 


 

 

 

 

 

 

 


Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.